Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Contract win with healthcare system provider

7th Apr 2017 07:00

RNS Number : 8595B
Fusionex International PLC
07 April 2017
 

RNS

7 April 2017

 

Fusionex International PLC

("Fusionex" or the "Group")

 

Contract win with multinational healthcare system provider

 

Fusionex, a leading provider of Analytics and Big Data software, is pleased to announce that it has won a new contract with a major multinational Asian healthcare company for GIANT 2017, its award-winning Big Data platform. The initial contract with the medical supplier is in the region of USD300,000, with the value expected to increase alongside the adoption rate within the client's various departments and at different offices across Asia.

 

GIANT 2017 will enable the client to gain intelligent e-commerce insights to boost revenues and improve overall system management by the medical professionals across the business through a wide spectrum of data analytics. GIANT 2017 enables administrators to monitor user preferences and needs, as well as identify the preferences of medical professionals whether in terms of equipment, events or reading materials.

 

The integrated regional medical supplier of equipment, supplies, and services supports a network of thousands of healthcare institutions, including government and private hospitals, surgery centers, specialist and primary care clinics, laboratories, and nursing homes across Asia.

 

Ivan Teh, Chief Executive Officer of Fusionex, commented:

"This GIANT win further demonstrates the capability and applicability of Big Data Analytics to the healthcare industry, a core focus for Fusionex. We are delighted to enter into the relationship and we know that the insights and benefits that GIANT will bring to medical professionals will ultimately help thousands of patients. The adoption of Big Data in healthcare is crucial and we believe that Fusionex will continue to generate significant revenues from the sector."

 

For further details:

Fusionex

Ivan Teh, Chief Executive Officer

Yuen Choong Lai, Chief Financial Officer

Darren Hopkins, Director of Investor Relations & Corporate Development

Through Buchanan

 

Stifel

Fred Walsh, Neil Shah, Ben Maddison, Rajpal Padam

0207 710 7600

 

Peel Hunt

0207 418 8900

Richard Kauffer, Euan Brown

 

Buchanan

Giles Sanderson, Steph Watson, Patrick Hanrahan

 

 020 7466 5000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUNUNRBAASRAR

Related Shares:

FXI.L
FTSE 100 Latest
Value8,275.66
Change0.00